Table 4.

The effect of the G haplotype on thrombin generation was determined after initiation at 13 pM TF in NIHR BioResource participants

CAT parameterVariableMedian (IQR)Wilcoxon rank sum P value
F5-G/G (n = 7)F5-ref (n = 13)
LT (min) No Ab (t−2.05 (1.67-2.22) 1.71 (1.5-1.81) .190 (N.S.) 
 Anti-TFPI (t+) 1.13 (1.11-1.44) 1.17 (1.11-1.31) .590 (N.S.) 
 Ratio (t−/t+1.53 (1.49-1.69) 1.42 (1.33-1.47) .00622∗∗ 
Peak (nM thrombin) No Ab 291 (247-300) 281 (255-316) .877 (N.S.) 
 Anti-TFPI 371 (337-383) 354 (294-365) .157 (N.S.) 
 Ratio 0.784 (0.657-0.884) 0.861 (0.807-0.892) .135 (N.S.) 
ttPeak (min) No Ab 4.28 (3.72-5.10) 3.72 (3.31-3.90) .0881 (N.S.) 
 Anti-TFPI 2.72 (2.67-3.00) 2.72 (2.64-2.90) .690 (N.S.) 
 Ratio 1.43 (1.37-1.89) 1.36 (1.24-1.44) .0557 (N.S.) 
ETP (nM thrombin × min) No Ab 1250 (1190-1300) 1170 (1060-1230) .115 (N.S.) 
 Anti-TFPI 1250 (1150-1300) 1160 (991-1200) .0811 (N.S.) 
 Ratio 1.02 (0.980-1.07) 1.05 (1.04-1.09) .135 (N.S.) 
CAT parameterVariableMedian (IQR)Wilcoxon rank sum P value
F5-G/G (n = 7)F5-ref (n = 13)
LT (min) No Ab (t−2.05 (1.67-2.22) 1.71 (1.5-1.81) .190 (N.S.) 
 Anti-TFPI (t+) 1.13 (1.11-1.44) 1.17 (1.11-1.31) .590 (N.S.) 
 Ratio (t−/t+1.53 (1.49-1.69) 1.42 (1.33-1.47) .00622∗∗ 
Peak (nM thrombin) No Ab 291 (247-300) 281 (255-316) .877 (N.S.) 
 Anti-TFPI 371 (337-383) 354 (294-365) .157 (N.S.) 
 Ratio 0.784 (0.657-0.884) 0.861 (0.807-0.892) .135 (N.S.) 
ttPeak (min) No Ab 4.28 (3.72-5.10) 3.72 (3.31-3.90) .0881 (N.S.) 
 Anti-TFPI 2.72 (2.67-3.00) 2.72 (2.64-2.90) .690 (N.S.) 
 Ratio 1.43 (1.37-1.89) 1.36 (1.24-1.44) .0557 (N.S.) 
ETP (nM thrombin × min) No Ab 1250 (1190-1300) 1170 (1060-1230) .115 (N.S.) 
 Anti-TFPI 1250 (1150-1300) 1160 (991-1200) .0811 (N.S.) 
 Ratio 1.02 (0.980-1.07) 1.05 (1.04-1.09) .135 (N.S.) 

Thrombin generation was assessed by CAT after initiation by 13pM TF in citrated plasma, collected in CTI, in the presence and absence of inhibitory anti-TFPI Abs. The LT, ttPeak, peak, and ETP of thrombin generation were calculated. The mean of 3 technical replicates of each parameter was calculated for each participant and then group medians were determined, which are represented in the table. The ratio for each parameter corresponds to the value determined by dividing the measurement in the absence of anti-TFPI Abs by that made in its presence. The values in parentheses next to the median values represent the lower and upper limits of the IQR. N.B. ∗∗P < .01.

Abbreviations are explained in Table 3.

or Create an Account

Close Modal
Close Modal